These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1968844)

  • 1. Sigma receptor blockade by BMY 14802 affects enkephalinergic and tachykinin cells differentially in the striatum of the rat.
    Angulo JA; Cadet JL; McEwen BS
    Eur J Pharmacol; 1990 Jan; 175(2):225-8. PubMed ID: 1968844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of dopamine receptor activity differentially alters striatal neuropeptide mRNA levels.
    Angulo JA; Christoph GR; Manning RW; Burkhart BA; Davis LG
    Adv Exp Med Biol; 1987; 221():385-91. PubMed ID: 3434462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of typical and atypical neuroleptic treatment on protachykinin mRNA levels in the striatum of the rat.
    Angulo JA; Cadet JL; McEwen BS
    Neurosci Lett; 1990 May; 113(2):217-21. PubMed ID: 1974041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic treatment with pentazocine or SFK 10047 decrease proenkephalin mRNA levels in the rat striatum and nucleus accumbens.
    Angulo JA; Ledoux M; McEwen BS
    Neurosci Lett; 1991 Jan; 122(1):47-9. PubMed ID: 1647506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases D2 dopamine receptor mRNA and proenkephalin mRNA and decreases D1 dopamine receptor mRNA and mu and delta opioid receptors in rat striatum.
    Chen JF; Aloyo VJ; Qin ZH; Weiss B
    Neurochem Int; 1994 Oct; 25(4):355-66. PubMed ID: 7820070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of dopamine D1 and D2 receptors in the regulation of proenkephalin mRNA abundance in the striatum and accumbens of the rat brain.
    Angulo JA
    J Neurochem; 1992 Mar; 58(3):1104-9. PubMed ID: 1346626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proenkephalin mRNA levels in rat striatum are increased and decreased, respectively, by selective D2 and D1 dopamine receptor antagonists.
    Morris BJ; Hunt SP
    Neurosci Lett; 1991 Apr; 125(2):201-4. PubMed ID: 1831887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haloperidol increases proenkephalin mRNA levels in the caudate-putamen of the rat: a quantitative study at the cellular level using in situ hybridization.
    Romano GJ; Shivers BD; Harlan RE; Howells RD; Pfaff DW
    Brain Res; 1987 Apr; 388(1):33-41. PubMed ID: 3580841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of risperidone and haloperidol on tachykinin and opioid precursor peptide mRNA levels in the caudate-putamen and nucleus accumbens of the rat.
    Mijnster MJ; Schotte A; Docter GJ; Voorn P
    Synapse; 1998 Apr; 28(4):302-12. PubMed ID: 9517839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of neuropeptide mRNA expression in intrastriatal striatal transplants by host dopaminergic afferents.
    Campbell K; Wictorin K; Björklund A
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10489-93. PubMed ID: 1438238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chronic typical and atypical neuroleptic treatment on proenkephalin mRNA levels in the striatum and nucleus accumbens of the rat.
    Angulo JA; Cadet JL; Woolley CS; Suber F; McEwen BS
    J Neurochem; 1990 Jun; 54(6):1889-94. PubMed ID: 1971007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalization of striatal proenkephalin and preprotachykinin mRNA expression by fetal substantia nigra grafts.
    Mendez IM; Naus CC; Elisevich K; Flumerfelt BA
    Exp Neurol; 1993 Jan; 119(1):1-10. PubMed ID: 8432341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of striatal opioid gene expression, and its modulation by the mesostriatal dopamine pathway: an in situ hybridization study.
    Morris BJ; Herz A; Höllt V
    J Mol Neurosci; 1989; 1(1):9-18. PubMed ID: 2561993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCH 58261, a selective adenosine A2A receptor antagonist, decreases the haloperidol-enhanced proenkephalin mRNA expression in the rat striatum.
    Wardas J; Pietraszek M; Dziedzicka-Wasylewska M
    Brain Res; 2003 Jul; 977(2):270-7. PubMed ID: 12834887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA.
    Cenci MA; Lee CS; Björklund A
    Eur J Neurosci; 1998 Aug; 10(8):2694-706. PubMed ID: 9767399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic regulation of tachykinin- and enkephalin-gene expression in the rat striatum.
    Lucas LR; Harlan RE
    Brain Res Mol Brain Res; 1995 Jun; 30(2):181-95. PubMed ID: 7637570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential ontogenetic expression and regulation of proenkephalin and preprosomatostatin mRNAs in rat caudate-putamen as studied by in situ hybridization histochemistry.
    Cimino M; Zoli M; Weiss B
    Brain Res Dev Brain Res; 1991 Jun; 60(2):115-22. PubMed ID: 1680033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional differences in substance P-like immunoreactivity in the striatum correlate with levels of pre-protachykinin mRNA.
    Chesselet MF; Robbins E
    Neurosci Lett; 1989 Jan; 96(1):47-53. PubMed ID: 2467230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental expression of proenkephalin mRNA in rat striatum and in striatal cultures.
    Schwartz JP; Simantov R
    Brain Res; 1988 May; 468(2):311-4. PubMed ID: 3382962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA receptor antagonist MK-801 down-regulates rat striatal proenkephalin and protachykinin mRNAs.
    Zhang F; Van Bree L; Albala N; Verslype M; Vanderhaeghen JJ
    Neurochem Int; 1996 Feb; 28(2):189-92. PubMed ID: 8719708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.